HR 2444
114th Congress
House
To authorize the Commissioner of Food and Drugs to award grants for studying the process of continuous drug manufacturing.
Health
Drug safety, medical device, and laboratory regulationEducation programs fundingHigher educationManufacturingResearch administration and funding
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 22, 2015
Referred to the Subcommittee on Health.
May 19, 2015
Referred to the House Committee on Energy and Commerce.
May 19, 2015
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Plain-English summary
This bill authorizes the Commissioner of Food and Drugs to award grants to institutions of higher education and nonprofit organizations to study and recommend improvements to the process of continuous manufacturing of drugs and biological products and similar innovative monitoring and control techniques.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
2
Cite this page
U.S. Congress. (2026). H.R. 2444: To authorize the Commissioner of Food and Drugs to award grants for studying the process of continuous drug manufacturing.. 114th Congress. Open America. https://openamerica.io/bill/114-HR-2444/
"H.R. 2444: To authorize the Commissioner of Food and Drugs to award grants for studying the process of continuous drug manufacturing.." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-2444/.
H.R. 2444, 114th Cong. (2026), https://openamerica.io/bill/114-HR-2444/.
[H.R. 2444: To authorize the Commissioner of Food and Drugs to award grants for studying the process of continuous drug manufacturing.](https://openamerica.io/bill/114-HR-2444/)